Cyclosphosphamide/prednisone for combination immunosuppression and therapy of lymphoproliferative disease.
J Heart Lung Transplant
; 18(5): 492-5, 1999 May.
Article
em En
| MEDLINE
| ID: mdl-10363695
ABSTRACT
Post-transplant lymphoproliferative disease (PTLD) is a well-known complication of solid organ transplantation. While this disorder can often be controlled by decreasing immunosuppression, it is frequently difficult to control the resultant rejection. This case exemplifies this dilemma. To solve this problem, cyclosphosphamide (600 mg/m2) and prednisone (2 mg/kg times 5 days) were given every 3 weeks to simultaneously treat PTLD and provide immunosuppression.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Prednisona
/
Terapia de Imunossupressão
/
Ciclofosfamida
/
Glucocorticoides
/
Imunossupressores
/
Transtornos Linfoproliferativos
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
/
Male
/
Newborn
Idioma:
En
Ano de publicação:
1999
Tipo de documento:
Article